International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8352550
Original Article
A Prospective Analytical Study on Comparison of Bipolar Transurethral Enucleation of Prostate Vs Bipolar Transurethral Resection of Prostate
 ,
 ,
 ,
 ,
Published
Sept. 17, 2023
Abstract

Objectives: The purpose of this study was to evaluate the safety and effectiveness of bipolar transurethral enucleation and resection of the prostate (TUEP) compared to bipolar transurethral resection of the prostate (TURP) in the treatment of enlarged prostate, with a focus on long-term results.

Materials and Methods: The present study conducted in patients admitted in Gandhi medical college associated Hamidia Hospital, Bhopal and carried out in Department of General Surgery. The study included 40 patients who admitted with the diagnosis of benign prostatic enlargement and underwent surgical treatment either by TEUP (n=20) or TURP (n=20) between the time periods of Jan 2021 to Sept. 2022. Patient characteristic and laboratory data were recorded and were examined pre and post operatively in terms of safety and efficacy.

Results: There were no significant differences in the preoperative parameters between groups. Comparing with TURP, TUEP had shorter time taken for surgery (33.5±3.28 and 46.75±7.99), more amount of tissue resected (33±8.74 and 26.5±9.45), minimal Post-OP-IPSS score (1.05±1.05 and 4.7±1.38) and fall in HB level (1.17±1.13 and 2.03±1.00) with statistically significant difference. In TUEP group significantly fewer reoperation and complications occurs with minimal Clavien-Dindo Grading(p-value-0.0003)as compared to TURP group. The statically significant lower mean hospital stay observed in TUEP and TURP groups (3.05±0.22 and 3.95±0.82, p-value-0.0298).

Conclusion: It is recommended that TUEP be chosen as the primary method for larger prostate sizes, as it has fewer complications, a shorter hospital stay, and greater safety and efficacy compared to TURP.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
2889 Views
472 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved